4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-21-022246
CEO & Chief Scientific Officer sold 48,847 shares at an average $18.93 ($924,750)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Scientific Officer | 2021-02-10 | Sale | −15,747 | $18.76 | $295,344 | 6,891,246 | I |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2021-02-11 | Sale | −19,823 | $19.06 | $377,884 | 6,871,423 | I |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2021-02-12 | Sale | −13,277 | $18.94 | $251,522 | 6,858,146 | I |
| Open-market sales · 48,847 sh · avg $18.93 · $924,750 | |||||||
Loading xslF345X03/a4.xml…